|
Video: What is a Stock Split?
|
|
First Trust NYSE Arca Biotechnology Index Fund is an open-end management company. The Fund seeks investment results that correspond generally to the price and yield of an equity index called the NYSE Arca Biotechnology Index (the Index). The Index is an equal dollar-weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. As of Dec 31 2013, the Fund's total assets were $983,610,857 and the Fund's investment portfolio was valued at $969,483,653. According to our FCG split history records, First Trust Exchange-Traded Fund - NYSE Arca Biotechnology Index Fund has had 1 split. | |
|
First Trust Exchange-Traded Fund - NYSE Arca Biotechnology Index Fund (FCG) has 1 split in our FCG split history database. The split for FCG took place on May 02, 2016. This was a 1 for 5 reverse split, meaning for each 5 shares of FCG owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.
When a company such as First Trust Exchange-Traded Fund - NYSE Arca Biotechnology Index Fund conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the FCG split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into First Trust Exchange-Traded Fund - NYSE Arca Biotechnology Index Fund shares, starting with a $10,000 purchase of FCG, presented on a split-history-adjusted basis factoring in the complete FCG split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
11/11/2014 |
|
End date: |
11/07/2024 |
|
Start price/share: |
$76.05 |
|
End price/share: |
$24.91 |
|
Starting shares: |
131.49 |
|
Ending shares: |
170.93 |
|
Dividends reinvested/share: |
$5.46 |
|
Total return: |
-57.42% |
|
Average Annual Total Return: |
-8.19% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,256.00 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/11/2014 |
|
End date: |
11/07/2024 |
|
Start price/share: |
$76.05 |
|
End price/share: |
$24.91 |
|
Dividends collected/share: |
$5.46 |
|
Total return: |
-60.06% |
|
Average Annual Total Return: |
-8.77% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,994.72 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
05/02/2016 | 1 for 5 |
|
|